AMGNAmgen

Health care · Biotechnology · Nasdaq

Amgen Inc. (including its subsidiaries, referred to as “Amgen,” “the Company,” “we,” “our” or “us”) discovers, develops, manufactures and delivers innovative medicines to fight some of the world’s toughest diseases. 10-K, Item 1

Headquarters: Thousand Oaks, CA
CEO: Robert A. Bradway
Next results: around Feb 2, 2027

Compare with peers → Embed

Every trade in AMGN shares that directors, officers and 10% owners reported on Form 4 since May 14, 2026. Open-market buys and sales are the trades the insider chose to make; grants, option exercises and shares withheld for tax are part of pay.

Bought on the market $0 0 trades by 0 insiders

Sold on the market $4.1M 6 trades by 3 insiders

All Buys and sales Buys Sales

Date	Insider	Role	Type	Shares	Price	Value	Owned after
Aug 13, 2026	Rachna Khosla	SVP, Business Development	Sale	-1,252	416.43	521K	6,404
Aug 11, 2026	Rachna Khosla	SVP, Business Development	Sale	-2,000	412.57	825K	6,404
Aug 6, 2026	Nancy A. Grygiel	SVP & CCO	Sale	-1,970	402.16	792K	7,340
Aug 6, 2026	Nancy A. Grygiel	SVP & CCO	Sale	-1,000	402.16	402K	7,340
Aug 6, 2026	Derek Miller	SVP, Human Resources	Sale	-2,069	402.54	833K	12,462
Aug 6, 2026	Derek Miller	SVP, Human Resources	Sale	-1,821	402.54	733K	12,462

From the Form 4s in SEC's filing index; each date links to the filing. The Insider selling plans tab shows planned sales (10b5-1 plans and Form 144).

Work on AMGN in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/AMGN/export.csv") into a cell.